• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ:TNXP)

    24.28 +0.28 (+1.17%)
    Streaming Delayed Price Updated: 2:31 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 770,273
    Open 24.04
    Bid (Size) 24.17 (1)
    Ask (Size) 24.39 (1)
    Prev. Close 24.00
    Today's Range 23.76 - 24.78
    52wk Range 6.760 - 130.00
    Shares Outstanding 8,765,896
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Fabrinet, Adecoagro And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
     
    Via Benzinga
    What's going on in today's session
    Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis. 
    Via Chartmill

    Performance

    YTD
    -22.7%
    -22.7%
    1 Month
    -28.6%
    -28.6%
    3 Month
    -31.7%
    -31.7%
    6 Month
    -9.0%
    -9.0%
    1 Year
    +84.5%
    +84.5%

    More News

    Read More
    Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    This Pharma Stock Shot Up 4% Pre-Market After FDA Approval For Drug, Retail’s Super Bullish But Believes ‘This Is A Marathon, Not A Sprint’
    Via Stocktwits
    Tonix Pharma Scores Best Day Since March On Hopes For First New Fibromyalgia Drug Approval in 16 Years; Retail’s Optimistic
    Via Stocktwits
    Monday's session: top gainers and losers
    Via Chartmill
    Let's uncover which stocks are experiencing notable gaps during today's session.
    Via Chartmill
    Tonix Pharma's Drug Gets FDA Nod For Chronic Pain Condition, First New Therapy In Over 15 Years
    Via Benzinga
    Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Wondering what's happening in today's after-hours session?
    Via Chartmill
    Why KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    What's Going On With Tonix Pharmaceuticals (TNXP) Stock?
    Via Benzinga
    Why Tonix Pharmaceuticals (TNXP) Stock Is Climbing This Week
    Via Benzinga
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
    Via Chartmill
    Mercury Systems Posts Better-Than-Expected Earnings, Joins Green Dot, Arcturus Therapeutics And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Tonix Pharmaceuticals (TNXP) Stock Surges On Q2 Earnings Beat And Upcoming FDA Catalyst
    Via Benzinga
    Topics Earnings
    Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators
    Via Investor Brand Network
    Topics Government
    Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators
    Via FinancialNewsMedia
    Topics Government
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present TNX-801 Mpox Vaccine Data at Vaccine Congress 2025
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Publishes Preclinical Data Supporting TNX-1700 as Immunotherapy Enhancer in Gastric Cancer
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Added to Russell 3000 and Russell 2000 Indexes
    Via Investor Brand Network
    InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Phase 3 Data on Fibromyalgia Drug at EULAR 2025
    Via Investor Brand Network

    Frequently Asked Questions

    Is Tonix Pharmaceuticals Holding Corp. - Common Stock publicly traded?
    Yes, Tonix Pharmaceuticals Holding Corp. - Common Stock is publicly traded.
    What exchange does Tonix Pharmaceuticals Holding Corp. - Common Stock trade on?
    Tonix Pharmaceuticals Holding Corp. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Tonix Pharmaceuticals Holding Corp. - Common Stock?
    The ticker symbol for Tonix Pharmaceuticals Holding Corp. - Common Stock is TNXP on the Nasdaq Stock Market
    What is the current price of Tonix Pharmaceuticals Holding Corp. - Common Stock?
    The current price of Tonix Pharmaceuticals Holding Corp. - Common Stock is 24.28
    When was Tonix Pharmaceuticals Holding Corp. - Common Stock last traded?
    The last trade of Tonix Pharmaceuticals Holding Corp. - Common Stock was at 09/26/25 02:31 PM ET
    What is the market capitalization of Tonix Pharmaceuticals Holding Corp. - Common Stock?
    The market capitalization of Tonix Pharmaceuticals Holding Corp. - Common Stock is 212.84M
    How many shares of Tonix Pharmaceuticals Holding Corp. - Common Stock are outstanding?
    Tonix Pharmaceuticals Holding Corp. - Common Stock has 213M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.